C1-esterase Inhibitor - Hereditary Angioedema Therapeutics Market
The global c1-esterase inhibitor hereditary angioedema therapeutics market size was valued at US$ 1,186.1 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 11% from 2023 to 2030.
Related Statistics
C1-esterase inhibitor - Hereditary angioedema therapeutics market highlights
- The global c1-esterase inhibitor segment generated a revenue of USD 1,186.1 million in 2023 and is expected to reach USD 2,466.8 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 10.9% by 2030.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Market summary
| Market revenue in 2023 | USD 1,186.1 million |
| Market revenue in 2030 | USD 2,466.8 million |
| Growth rate | 10.9% (CAGR from 2024 to 2030) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hereditary Angioedema Therapeutics Market Scope
Hereditary angioedema therapeutics market segmentation & scope
Hereditary Angioedema Therapeutics Market
- HTML
- PPT
- -
Everything on Hereditary Angioedema Therapeutics Market in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
